For Immediate Release
Contact: Scott Sieber, 718-670-1579
Flushing, NY, June 22, 2009 – Diabetes is a public health crisis in this country, and in the New York City region. Nearly 24 million children and adults in the United States have diabetes. This disease contributes to the deaths of more than 230,000 people each year and costs our nation $174 billion annually. One of the physicians on the national forefront of fighting diabetes practices medicine right here in Queens. Now, he has been recognized for his contributions by the world’s foremost organization for diabetes research and education.
The American Diabetes Association with its “Outstanding Physician Clinician Award” lauded Daniel Lorber, M.D., F.A.C.P., C.D.E, an endocrinologist with New York Hospital Queens, and associate director at the hospital’s Lang Center for Research and Education. He was recognized at the association’s 69th annual Scientific Sessions. At this annual conference, 15,000 scientists, physicians and health care professionals from around the world gathered in New Orleans to share cutting edge research, treatment recommendations, and advances toward a cure.
“We’ve been able to do wonderful things at New York Hospital Queens in terms of improving diabetes care for our patients,” Lorber said. “This award is a result of the collaborative efforts of our team. We have implemented new procedures for insulin treatment and cut in half the rate of hypoglycemia through a collaborative effort of our diabetes team and pharmacy. I am grateful that I am able to bring this national recognition home to New York Hospital Queens.”
“Dr. Lorber has spent his life pursuing excellence in endocrinology,” said Toni Riedel-Lehmann, associate director of American Diabetes Association - Long Island Chapter. “His clinical efforts have benefited his own patients while his research work has helped advance the entire discipline of diabetes care.”
At the medical conference, the diabetes experts from New York Hospital Queens earned additional recognition when a landmark study was presented that explores treatmentapproaches for people with both Type 2 diabetes and coronary artery disease. This study, called BARI 2D, was published in the “New England Journal of Medicine” (NEJM), June 11. Dr. Lorber participated in the national study, and his colleague, Phyllis August, M.D., M.P.H., director, Lang Research Center for Research and Education, served as a co-investigator and co-author of the article published in NEJM.
Lorber also serves as a clinical associate professor of medicine at the Weill Medical College of Cornell University. An active member of the American Diabetes Association since 1980, he is past member of the Association’s national board of directors and currently serves on the legal advocacy subcommittee. Additionally, Lorber is one of the top fundraisers for the Step Out: Walk to Fight Diabetes, a fundraising effort to find a cure for diabetes.
New York Hospital Queens is a member of the NewYork-Presbyterian Healthcare System and an affiliate of the Weill Medical College of Cornell University.
|Pictured, Daniel Lorber, M.D., (r.) director of endocrinology, associate director of research, Eugene and Theresa Lang Center for Research and Education, New York Hospital Queens, receives the “Outstanding Clinician Physician Award” from American Diabetes Association President, Medicine and Science, R. Paul Robertson, M.D.|
Note to editors: Dr. Lorber is a resident of Port Washington, N.Y.